Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod
Clinical trial NCT01499667 · TERMINATED
Trial details
- NCT number
- NCT01499667
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-11-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.